Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) — Medicare Part D spending
Multiple manufacturers (9) · Rank #260 by total Part D spend · CMS data year 2023
Medicare Part D spent $174,703,369 on Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) in 2023, the #260 drug by total Part D spending out of 3,598 drugs. That worked out to about $43.62 per dosage unit, $2,067 per claim and $10,776 per beneficiary, across 84,533 claims for 16,212 beneficiaries. Average spending per dosage unit rose +8.2% from 2022. These are aggregate Medicare program figures (gross drug cost), not the price you pay.
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) spending at a glance (2023)
| Metric | Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) |
|---|---|
| Total Part D spending (2023) | $174,703,369 |
| Total spending (2022) | $156,939,248 |
| Year-over-year change in total spending | +11.3% |
| Average spending per dosage unit (2023) | $43.62 |
| Change in spend per dosage unit (YoY) | +8.2% |
| Avg annual change per dosage unit (2019-2023 CAGR) | +4.5% |
| Average spending per claim (2023) | $2,067 |
| Average spending per beneficiary (2023) | $10,776 |
| Total claims (2023) | 84,533 |
| Beneficiaries (2023) | 16,212 |
| Total dosage units (2023) | 4,092,664 |
| Manufacturer(s) | Multiple manufacturers (9) |
| National rank by total spend (of 3,598 drugs) | #260 |
Source: CMS Medicare Part D Spending by Drug (data year 2023). Data as of June 2026.
2022 vs 2023
| Metric | 2022 | 2023 | Change |
|---|---|---|---|
| Total spending | $156,939,248 | $174,703,369 | +11.3% |
| Avg spend per dosage unit | $40.32 | $43.62 | +8.2% |
| Avg spend per claim | $1,924 | $2,067 | — |
| Avg spend per beneficiary | $9,859 | $10,776 | — |
| Total claims | 81,566 | 84,533 | — |
| Beneficiaries | 15,919 | 16,212 | — |
How Omeprazole-Sodium Bicarbonate compares with nearby drugs
Drugs with total Part D spending closest to Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate):
| Drug (rank) | Total spend 2023 | Per dosage unit | Per-unit YoY |
|---|---|---|---|
| Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) (this drug, #260) | $174,703,369 | $43.62 | +8.2% |
| Lonsurf (Trifluridine/Tipiracil HCl) (#258) | $176,155,837 | $257.01 | +5.4% |
| Rhopressa (Netarsudil Mesylate) (#259) | $174,888,744 | $130.78 | +5.8% |
| Sertraline HCl (#261) | $173,568,167 | $0.19 | +3.4% |
| Mekinist (Trametinib Dimethyl Sulfoxide) (#262) | $173,398,802 | $407.94 | +7.8% |
| Simvastatin (#263) | $172,937,895 | $0.14 | +20.9% |
Frequently asked questions
How much does Medicare Part D spend on Omeprazole-Sodium Bicarbonate?
Medicare Part D spent $174,703,369 on Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) in 2023 (the latest CMS data year), across 84,533 claims for 16,212 beneficiaries. That ranks #260 of 3,598 drugs by total Part D spending. This is gross drug cost (Medicare, plan and beneficiary payments combined), not the price you personally pay.
What is the average spending per dosage unit for Omeprazole-Sodium Bicarbonate?
In 2023, the weighted average Medicare Part D spending per dosage unit for Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) was $43.62. Compared with 2022 it rose +8.2%. A "dosage unit" is one pill, tablet, milliliter or other billing unit, so this is not the price of a prescription.
Who makes Omeprazole-Sodium Bicarbonate?
CMS attributes Omeprazole-Sodium Bicarbonate (Omeprazole/Sodium Bicarbonate) to Multiple manufacturers (9) in the 2023 Part D spending file. Average spending per claim was $2,067 and per beneficiary $10,776.
Is the Omeprazole-Sodium Bicarbonate figure the price I pay?
No. These are aggregate Medicare Part D program figures (total gross drug cost and averages across all claims), published by CMS for transparency. Your out-of-pocket cost depends on your plan, formulary, deductible and coverage phase. Always check your plan and talk to your pharmacist or doctor.
Keep exploring
Source & what this means
Figures are from the CMS Medicare Part D Spending by Drug dataset (data year 2023, US public domain). "Total spending" is the gross drug cost — Medicare, plan and beneficiary payments combined — for Part D claims; it is not a list price, a negotiated price, or what any individual pays. Spending per dosage unit is volume-weighted across formulations. This is general public-spending information, not medical or pricing advice. Your own cost depends on your plan, deductible and coverage phase — verify with your Part D plan and a pharmacist. Data as of June 2026. See our methodology and disclaimer.
Last updated: 2026-06-20